semaglutide and citalopram Diabetes Drug Could Help Reduce Risk for Cardiovascular Events, Study Finds Antidepressants 'Don't Blunt' Semaglutide and

Reduction in Cardiovascular Risk: The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events with semaglutide in overweight and obese patients with established CVD independent of diabetes status or the degree of weight loss achieved

From there, we create a plan for you that may include: Prescription weight loss medications Routine communication directly with your provider no more leaving messages with the front desk or waiting for your provider to reach out to you

CGM data helps your physician make informed decisions about concomitant medication adjustment and semaglutide dose timing

This podcast explores my journey, thoughts, and conversations into the body's potential to heal from disease and thrive